Assessing the Risk and Potential of Relay Therapeutics Inc’s (RLAY) Stock
The stock of Relay Therapeutics Inc (RLAY) has seen a -12.58% decrease in the past week, with a -25.40% drop in the past month, and
The stock of Relay Therapeutics Inc (RLAY) has seen a -12.58% decrease in the past week, with a -25.40% drop in the past month, and
The stock price of Relay Therapeutics Inc (NASDAQ: RLAY) has plunged by -10.61 when compared to previous closing price of 9.14, but the company has
The 36-month beta value for RLAY is also noteworthy at 1.66. There are mixed opinions on the stock, with 0 analysts rating it as a
Additionally, the 36-month beta value for RLAY is 1.68. The public float for RLAY is 88.49M and currently, short sellers hold a 10.68% ratio of
The stock of Relay Therapeutics Inc (NASDAQ: RLAY) has increased by 9.25 when compared to last closing price of 22.51. Despite this, the company has
The stock of Relay Therapeutics Inc (RLAY) has gone down by -2.41% for the week, with a -25.11% drop in the past month and a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.